Alpha DNA Investment Management’s Becton Dickinson BDX Stock Holding History

Alpha DNA Investment Management’s Portfolio BDX Stock Details BDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,164	Closed	-$1.85M	–	29
2024 Q4	$1.85M	Buy	8,164 +413	+5%	+$95.4K	0.71%	29
2024 Q3	$1.87M	Buy	7,751 +165	+2%	+$38.7K	0.7%	32
2024 Q2	$1.77M	Sell	7,586 -277	-4%	-$65.3K	0.69%	34
2024 Q1	$1.95M	Buy	7,863 +382	+5%	+$91.4K	0.72%	29
2023 Q4	$1.82M	Sell	7,481 -535	-7%	-$132K	0.71%	27
2023 Q3	$2.07M	Buy	+8,016	New	+$2.17M	0.85%	14
2023 Q2	–	Sell	-8,272	Closed	-$2.05M	–	161
2023 Q1	$2.05M	Buy	8,272 +92	+1%	+$22.5K	0.6%	15
2022 Q4	$2.08M	Buy	8,180 +5,689	+228%	+$1.34M	0.74%	10
2022 Q3	$555K	Buy	+2,491	New	+$620K	0.46%	100

Other funds holding BDX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Alpha DNA Investment Management's BDX Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Becton Dickinson (BDX) in Q1 2025, closing a stake of 8,164 shares — an estimated $1.85M sold.

Alpha DNA Investment Management first reported a position in BDX in Q3 2022 and held it in 9 quarters. The position peaked at $2.08M in Q4 2022. 1,609 funds tracked by Wall St. Rank hold BDX as of Q1 2025.

Alpha DNA Investment Management reported no remaining Becton Dickinson position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 8,164 Becton Dickinson shares in Q1 2025, an estimated $1.85M.
Alpha DNA Investment Management first reported a position in Becton Dickinson in Q3 2022 and held it in 9 quarters.
Alpha DNA Investment Management's Becton Dickinson position peaked at $2.08M in Q4 2022.
1,609 funds tracked by Wall St. Rank held Becton Dickinson as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.